General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. A Surgical Stapling Device is a medical device that is used to join tissues by implanting staples after surgery and, in turn, promote healing. GlobalData uses proprietary data and analytics to provide a comprehensive report on the surgical stapling devices devices market, including market shares of different players within India. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the surgical stapling devices market in India was Ethicon followed by Medtronic, Smith & Nephew, 3M, CooperSurgical, Teleflex and ConMed.
Surgical Stapling Device can be broadly classified into External and Internal Surgical Stapling Devices. External Surgical Stapling Devices are used to apply staples on the skin to close wounds or external surgical incisions after various interventions. Surgeons use Internal Surgical Stapling Devices to apply staples that hold internal tissues together following various interventions.
The value of the surgical stapling devices devices market within India was expected to be over $100m in 2023.
For the latest complete market share analysis of surgical stapling devices device market in India, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
